Non-opioid Pain Patch Market Trends

Growth Drivers

Rising Trend of Minimally Invasive Procedures – Non-opioid pain patch are kind of minimally invasive treatments as they aid in administrating non-addictive pain medication by being applied to the skin similar to a bandage.
Growing Geriatric Population- Even though there are numerous options for pain alleviation, a large number of older persons choose not to seek therapy and opt for patch such as transdermal patch which are frequently used to address chronic pain in older adults.
Lately, more than 8% of the global population, are 65 years of age or older.
Non-Opioid Pain Patch for the Treatment of Cancer- If a doctor wants to use fewer opioids’ patients with cancer pain can safely and effectively use a lidocaine or buprenorphine patch for 3-5 days that might be able to help with pain management.

Challenges

Presence of Other Pain Management Strategies - Apart from non-opioid pain patch pain management techniques include at-home therapies such as yoga, psychological therapies including cognitive behavioral therapy, relaxation techniques, and meditation, mind-body techniques, massage therapy, and aqua therapy that can benefit people who suffer from low back pain, migraines, fibromyalgia, arthritis, and other chronic pain as they are simple, accessible, and safe method of managing pain that people can use in a class with an instructor or at home with online videos.
There are numerous drugs available to manage pain including acetaminophen a first choice for many types of pain, paracetamol which is advised as the initial medication to treat acute pain, and other medications including aspirin, ibuprofen, and naproxen that are usually used to treat minor to severe pain.
Furthermore, the two easiest and least expensive ways to get rid of acute and chronic pain are heat and cold therapy which also help increase blood flow and metabolism.
Stringent Rules & Regulations for Product Approval
Exorbitant Cost of Pain Patch Resulting from Disruptions in Supply Chain

Non-opioid Pain Patch Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	4.2%
Base Year Market Size (2024)	USD 3.61 billion
Forecast Year Market Size (2037)	USD 6.16 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of non-opioid pain patch is assessed at USD 3.73 billion.

The non-opioid pain patch market size was valued at USD 3.61 billion in 2024 and is likely to reach USD 6.16 billion by the end of 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. Growing burden of diabetes across the globe and The growing development of advanced products will drive the market growth.

North America industry is likely to dominate majority revenue share 51% by 2037, impelled by presence of key players which has led to the development of new products in the region.

The major players in the market are GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc., and others.

Non-opioid Pain Patch Market Trends